Inova in the News
“Should Runners Be Worried About Colon Cancer?,” Runner’s World, September 19, 2025
While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening…
Read More“Are Marathons and Extreme Running Linked to Colon Cancer?,” New York Times, August 19, 2025
Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured…
Read MoreBaxter IV shortage: Inova’s immediate recommendations for urology practices
The Impact of Hurricane Helene Destruction of Baxter Factory: Immediate Recommendations for Urology Practices in United States to Preserve IV (Intravenous) and other Fluids By Inger Rosner, MD and J. Stephen Jones, MDInova Health System, Fairfax VA Hurricane Helene has caused widespread devastation, resulting in loss of life, homes, and businesses. A significant consequence of…
Read More“Want to give back to your community immediately? Donate blood or host a blood drive,” WTOP, February 22, 2024
Every 2 seconds, someone in the United States needs blood. One blood donation can save up to three lives. Nicholas Lilly, senior director of Inova Blood Donor Services spoke with WTOP as part of their 2024 Get on Top of Your Health series.
Read MoreCancer-free “Voice of DC” shares message of hope
Known as the “Voice of DC,” WTOP reporter Neal Augenstein continues to share his inspiring journey from a stage-4 lung cancer diagnosis in November 2022 to becoming cancer-free a year later. Last week, Neal’s story of the ground-breaking medical treatment he received at Inova Schar Cancer was featured on NBC News. In the piece, Amit…
Read MoreDr. Stephen Jones: Prosecuting nurses for honest mistakes won’t make patients safer
Inova’s president and CEO J. Stephen Jones, MD, MBA, FACS had an op-ed piece published in USA Today following Friday’s sentencing of nurse RaDonda Vaught. (While working as a nurse at Vanderbilt University Medical Center in 2017, Vaught’s accidental administration of the wrong drug to a patient led to the patient’s death. Vaught was later…
Read MoreDr. Stephen Jones: It’s time for us to step up for healthcare workers
The Richmond Times-Dispatch has published an op-ed piece by Inova President and CEO J. Stephen Jones, MD, MBA, FACS, that articulates the issue of increasing physical and emotional violence directed at healthcare workers. Jones describes several recent incidents at Inova, including a nurse being told by a patient that the patient only wanted to “be…
Read MoreIs Radiation Necessary After Breast Cancer Surgery?
Ductal carcinoma in situ (DCIS) is a cancer that forms in the cells that line the milk ducts, and it accounts for 20% of new breast cancer diagnoses. The most common treatment is breast-conserving surgery to remove the cancerous tissue. While only a small percentage of women experience an invasive cancer event following surgery, radiation…
Read MoreInova’s Dr. Aragon-Ching Part of International Team Showing Benefit of Immunotherapy in Bladder Cancer Treatment
Jeanny B. Aragon-Ching, MD of the Inova Schar Cancer Institute has co-authored a groundbreaking bladder cancer research paper just published in the New England Journal of Medicine. The large phase III clinical study showed that the addition of immunotherapy with Avelumab (Bavencio) increased the duration of overall survival by almost 50% in patients when given…
Read MoreBoseman’s Death from Colon Cancer Part of Larger Trend, Says Inova’s Dr. Tim Cannon
A Good Morning America segment on the recent death from colon cancer of Hollywood actor Chadwick Boseman featured an interview with Inova’s Dr. Timothy Cannon of the Inova Schar Cancer Institute. Dr. Cannon noted that while overall colon cancer numbers are declining, it has been appearing more frequently in men under the age of 50…
Read More